BRBR vs. CPRX
BRBR (BellRing Brands, Inc.) and CPRX (Catalyst Pharmaceuticals, Inc.) are both stocks. BRBR operates in Packaged Foods (Consumer Defensive), while CPRX operates in Biotechnology (Healthcare). Over the past 5 years, BRBR returned -22.71%/yr vs 40.76%/yr for CPRX. At a 0.22 correlation, their price movements are largely independent.
Performance
BRBR vs. CPRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BRBR achieves a -70.45% return, which is significantly lower than CPRX's 34.02% return.
BRBR
- 1D
- -9.92%
- 1M
- -23.38%
- YTD
- -70.45%
- 6M
- -74.11%
- 1Y
- -87.04%
- 3Y*
- -39.59%
- 5Y*
- -22.71%
- 10Y*
- —
CPRX
- 1D
- 0.03%
- 1M
- 0.42%
- YTD
- 34.02%
- 6M
- 35.06%
- 1Y
- 20.91%
- 3Y*
- 39.11%
- 5Y*
- 40.76%
- 10Y*
- 48.01%
BRBR vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
BRBR BellRing Brands, Inc. | -70.45% | -64.52% | 35.92% | 116.19% | -10.13% | 17.36% | 14.19% | 29.03% |
CPRX Catalyst Pharmaceuticals, Inc. | 34.02% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | -29.25% |
Correlation
The correlation between BRBR and CPRX is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Oct 18, 2019 | 0.22 |
The correlation between BRBR and CPRX shifts across timeframes, from 0.08 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.
Fundamentals
BRBR:
$937.73M
CPRX:
$3.97B
BRBR:
$0.65
CPRX:
$1.74
BRBR:
12.10
CPRX:
17.98
BRBR:
2.99
CPRX:
0.32
BRBR:
0.42
CPRX:
6.67
BRBR:
$2.33B
CPRX:
$596.96M
BRBR:
$703.50M
CPRX:
$378.23M
BRBR:
$287.10M
CPRX:
$313.50M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BRBR vs. CPRX — Risk / Return Rank
BRBR
CPRX
BRBR vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BellRing Brands, Inc. (BRBR) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BRBR | CPRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.82 | ||
| Sortino ratioReturn per unit of downside risk | -3.74 | ||
| Omega ratioGain probability vs. loss probability | 0.59 | 1.14 | -0.55 |
| Calmar ratioReturn relative to maximum drawdown | -1.00 | 0.77 | -1.77 |
| Martin ratioReturn relative to average drawdown | -1.53 | 1.40 | -2.93 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BRBR | CPRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.19 | 0.63 | -1.82 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.48 | 0.86 | -1.34 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.80 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.23 | 0.09 | -0.31 |
Drawdowns
BRBR vs. CPRX - Drawdown Comparison
The maximum BRBR drawdown since its inception was -90.05%, roughly equal to the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for BRBR and CPRX.
Loading charts...
Drawdown Indicators
| BRBR | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.05% | -94.25% | +4.20% |
Max Drawdown (1Y)Largest decline over 1 year | -87.43% | -27.29% | -60.14% |
Max Drawdown (3Y)Largest decline over 3 years | -90.05% | -27.29% | -62.76% |
Max Drawdown (5Y)Largest decline over 5 years | -90.05% | -45.37% | -44.68% |
Max Drawdown (10Y)Largest decline over 10 years | — | -64.87% | — |
Current DrawdownCurrent decline from peak | -90.05% | -0.16% | -89.89% |
Average DrawdownAverage peak-to-trough decline | -19.51% | -52.02% | +32.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 56.77% | 14.95% | +41.82% |
Volatility
BRBR vs. CPRX - Volatility Comparison
BellRing Brands, Inc. (BRBR) has a higher volatility of 18.90% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 0.44%. This indicates that BRBR's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BRBR | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.90% | 0.44% | +18.46% |
Volatility (6M)Calculated over the trailing 6-month period | 65.86% | 23.50% | +42.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 73.31% | 33.58% | +39.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.07% | 47.80% | -0.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.66% | 60.47% | -13.81% |
Dividends
BRBR vs. CPRX - Dividend Comparison
Neither BRBR nor CPRX has paid dividends to shareholders.
Financials
BRBR vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between BellRing Brands, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BRBR vs. CPRX - Profitability Comparison
BRBR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BellRing Brands, Inc. reported a gross profit of 164.20M and revenue of 598.70M. Therefore, the gross margin over that period was 27.4%.
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.
BRBR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BellRing Brands, Inc. reported an operating income of 66.00M and revenue of 598.70M, resulting in an operating margin of 11.0%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.
BRBR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BellRing Brands, Inc. reported a net income of -43.70M and revenue of 598.70M, resulting in a net margin of -7.3%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.
Frequently Asked Questions
BRBR and CPRX have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BRBR has higher volatility (18.90%) compared to CPRX (0.44%). In terms of maximum drawdown, BRBR dropped -90.05% vs CPRX's -94.25%.
CPRX currently has the higher Sharpe Ratio (0.63 vs -1.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BRBR and CPRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer